2022 Max Planck Epigenetics Meeting
In-Person | 30 November - 2 December 2022
IMPORTANT UPDATE:
2022 EPIGENETICS MEETING PROGRAM PUBLISHED
From the organizers
Since 2010, the Max Planck Freiburg Epigenetics Meeting has established a tradition as one of the key events in chromatin and epigenetic research that provides a highly interactive platform in a very familiar setting. The meeting is held every second year in early December and we are very pleased to have an exciting line-up of 25 invited speakers.
After we had to postpone the meeting in December 2020 because of the Corona restrictions, we are now opening this Max Planck Freiburg Epigenetics Meeting as an in-person conference. We will provide the following format, which is at a reduced audience and can have 80-100 participants in a comfortable setting. Up to 10 short talks will be selected from the submitted abstracts. We will also have one poster session of around 30-40 posters. Talks and poster session will be made accessible to members of the MPI-IE via in-house zoom streaming and on-site interactions.
Personal contacts are essential and this format will offer an excellent platform to meet with leaders in the chromatin and epigenetics fields and to have informal interactions in a very familiar setting. We will not provide virtual platforms or live streaming of this Max Planck Freiburg Epigenetics Meeting outside the Institute. We hope that you find this format exciting and we are looking very much forward to welcoming you in-person to the Max Planck Freiburg 6th Epigenetics Meeting.
Practical Information
- Online registration will start on 1 June 2022
Registration deadline 1 September 2022Extension registration deadline 14 September 2022- Registration fee: Academia 650 Euro | Industry 850 Euro
Confirmed Speakers
Karim-Jean Armache
New York University, USA
Roberto Bonasio
University of Pennsylvania, USA
Ibrahim Cissé
MPI of Immunobiology and Epigenetics, Germany
Anne Ferguson-Smith
University of Cambridge, UK
Amanda Fisher
Imperial College London, UK
Andreas Houben
Leibniz Institute of Plants Genetics, Gatersleben, Germany
Nicola Iovino
MPI of Immunobiology and Epigenetics, Freiburg Germany
Cigall Kadoch
Harvard Medical School, USA
Jeannie Lee
Massachussetts General Hospital, USA
Rob Martienssen
Cold Spring Harbor Laboratory, USA
Geeta Narlikar
University of California, San Francisco, USA
Dónal O’Carroll
University of Edinburgh, UK
Clodagh O’Shea
The Salk Institute, USA
Ana Pombo
Max Delbrueck-Center, Berlin, Germany
Andrew Pospisilik
Van Andel Research Institute, USA
Nick Proudfoot
University of Oxford, UK
Oded Rechavi
Tel Aviv University, Israel
Wolf Reik
The Babraham Institute, UK
Danny Reinberg
New York University, USA
Bing Ren
Ludwig Institute for Cancer Research, USA
Claire Rougeulle
CNRS Paris, France
Dirk Schübeler
Friedrich Miescher Institute, Basel, Switzerland
Schraga Schwartz
Weizmann Institute of Science, Israel
Ali Shilatifard
Northwestern University, USA
Bas van Steensel
Netherlands Cancer Institute, The Netherlands
Yang Shi
Harvard Medical School, USA